Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis

Abstract Background Newborn screening (NBS) for cystic fibrosis (CF) not only identifies infants with a diagnosis of CF, but also those with an uncertain diagnosis of cystic fibrosis (CF), i.e. CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive inco...

Full description

Bibliographic Details
Main Authors: Chee Y. Ooi, Rosie Sutherland, Carlo Castellani, Katherine Keenan, Margaret Boland, Joe Reisman, Candice Bjornson, Mark A. Chilvers, Richard van Wylick, Steven Kent, April Price, Dimas Mateos-Corral, Daniel Hughes, Melinda Solomon, Peter Zuberbuhler, Janna Brusky, Peter R. Durie, Felix Ratjen, Tanja Gonska
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Pediatrics
Subjects:
CF screen positive inconclusive diagnosis (CFSPID)
CFTR-related metabolic syndrome (CRMS)
Newborn screening
Sweat test
Trypsinogen
Online Access:http://link.springer.com/article/10.1186/s12887-019-1756-4

Internet

http://link.springer.com/article/10.1186/s12887-019-1756-4

Similar Items